申请人:Recordati S.A.
公开号:US04275071A1
公开(公告)日:1981-06-23
Imidazole derivatives of the formula I and pharmaceutically acceptable acid addition salts thereof are provided: ##STR1## In the formula, R.sub.4 1- or 2-naphthyl, optionally substituted with Cl, Br, or I; 1,2,3,4-tetrahydro-6-naphthyl; 3-duryl, optionally 6-substituted by Cl, Br, I, NO.sub.2, CH.sub.3 or benzyl; mesityl, phenyl 2-, 3- or 4-substituted by OH, NH.sub.2, NO.sub.2, CH.sub.3 CONH, phenyl, phenoxy, cyclohexyl, phenylthio, benzylthio, C.sub.1 -C.sub.6 alkyl or C.sub.1 C.sub.6 alkylthio; 4-bibenzylyl; 3,4-dihydroxyphenyl, n=0, 1 or 2 and (a) R=H, alkyl having 1 to 6 carbon atoms or phenyl R.sub.1 =H, alkyl having 1 to 6 carbon atoms or phenyl one of R.sub.2 and R.sub.3 =H the other of R.sub.2 and R.sub.3 =H, OH, benzoyloxy, C.sub.2 -C.sub.7 alkanoyloxy, N-(C.sub.1 -C.sub.6 alkyl)-carbamoyloxy, N,N-[di-(C.sub.1 C.sub.6)alkyl]-carbamoyloxy, but if R.sub.2 =R.sub.3 =H then R=R.sub.1 =H, or (b) R=H, C.sub.1 -C.sub.6 alkyl, phenyl R.sub.1 =H, C.sub.1 -C.sub.6 alkyl, phenyl R.sub.2 +R.sub.3 =O, or ##STR2## The compounds of formula I are anti-convulsivants.
提供公式I的咪唑衍生物及其药学上可接受的酸盐:##STR1##
在公式中,R.sub.4为1-或2-萘基,可选择性地用Cl,Br或I取代;1,2,3,4-四氢-6-萘基;3-苯基,可选择性地6-取代为Cl,Br,I,NO.sub.2,CH.sub.3或苄基;mesityl,2-,3-或4-取代为OH,NH.sub.2,NO.sub.2,CH.sub.3CONH,苯基,苯氧基,环己基,苯硫基,苄硫基,C.sub.1-C.sub.6烷基或C.sub.1-C.sub.6烷基硫代基的苯基;4-联苄基;3,4-二羟基苯基,n = 0,1或2,且(a)R = H,具有1至6个碳原子的烷基或苯基;R.sub.1 = H,具有1至6个碳原子的烷基或苯基;R.sub.2和R.sub.3中的其中一个为H,另一个为H,OH,苯甲酰氧基,C.sub.2-C.sub.7烷酰氧基,N-(C.sub.1-C.sub.6烷基)-氨甲酰氧基,N,N-[二(C.sub.1-C.sub.6)烷基]-氨甲酰氧基,但如果R.sub.2 = R.sub.3 = H,则R = R.sub.1 = H,或(b)R = H,C.sub.1-C.sub.6烷基,苯基;R.sub.1 = H,C.sub.1-C.sub.6烷基,苯基;R.sub.2 + R.sub.3 = O,或##STR2##
公式I的化合物是抗惊厥剂。